Covalon Technologies (CVE:COV) Trading Up 2.1% – Here’s What Happened

Covalon Technologies Ltd. (CVE:COV)’s share price was up 2.1% during trading on Tuesday . The company traded as high as C$1.99 and last traded at C$1.99. Approximately 320 shares were traded during mid-day trading, a decline of 97% from the average daily volume of 12,055 shares. The stock had previously closed at C$1.95.

Covalon Technologies Stock Up 2.1%

The business’s fifty day moving average price is C$1.87 and its 200 day moving average price is C$1.83. The firm has a market capitalization of C$54.96 million, a price-to-earnings ratio of 66.33 and a beta of 1.11. The company has a current ratio of 5.69, a quick ratio of 6.45 and a debt-to-equity ratio of 7.82.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.